Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $8.87 billion. The enterprise value is $8.04 billion.
| Market Cap | 8.87B |
| Enterprise Value | 8.04B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 65.27 million shares outstanding. The number of shares has increased by 8.19% in one year.
| Current Share Class | 65.27M |
| Shares Outstanding | 65.27M |
| Shares Change (YoY) | +8.19% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 101.14% |
| Float | 53.45M |
Valuation Ratios
The trailing PE ratio is 27.58 and the forward PE ratio is 60.93.
| PE Ratio | 27.58 |
| Forward PE | 60.93 |
| PS Ratio | 16.08 |
| Forward PS | 35.15 |
| PB Ratio | 8.17 |
| P/TBV Ratio | 8.18 |
| P/FCF Ratio | 81.27 |
| P/OCF Ratio | 80.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.78, with an EV/FCF ratio of 73.70.
| EV / Earnings | 23.50 |
| EV / Sales | 14.58 |
| EV / EBITDA | 24.78 |
| EV / EBIT | 24.90 |
| EV / FCF | 73.70 |
Financial Position
The company has a current ratio of 19.85, with a Debt / Equity ratio of 0.01.
| Current Ratio | 19.85 |
| Quick Ratio | 19.76 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.08 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 39.56% and return on invested capital (ROIC) is 174.60%.
| Return on Equity (ROE) | 39.56% |
| Return on Assets (ROA) | 21.85% |
| Return on Invested Capital (ROIC) | 174.60% |
| Return on Capital Employed (ROCE) | 29.61% |
| Weighted Average Cost of Capital (WACC) | 10.93% |
| Revenue Per Employee | $3.91M |
| Profits Per Employee | $2.43M |
| Employee Count | 141 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $7.99 million in taxes.
| Income Tax | 7.99M |
| Effective Tax Rate | 2.28% |
Stock Price Statistics
The stock price has increased by +70.86% in the last 52 weeks. The beta is 1.22, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | +70.86% |
| 50-Day Moving Average | 141.35 |
| 200-Day Moving Average | 118.24 |
| Relative Strength Index (RSI) | 45.06 |
| Average Volume (20 Days) | 664,860 |
Short Selling Information
The latest short interest is 10.30 million, so 15.78% of the outstanding shares have been sold short.
| Short Interest | 10.30M |
| Short Previous Month | 9.35M |
| Short % of Shares Out | 15.78% |
| Short % of Float | 19.26% |
| Short Ratio (days to cover) | 12.29 |
Income Statement
In the last 12 months, PTGX had revenue of $551.69 million and earned $342.26 million in profits. Earnings per share was $4.93.
| Revenue | 551.69M |
| Gross Profit | 550.59M |
| Operating Income | 323.10M |
| Pretax Income | 350.25M |
| Net Income | 342.26M |
| EBITDA | 324.68M |
| EBIT | 323.10M |
| Earnings Per Share (EPS) | $4.93 |
Balance Sheet
The company has $800.06 million in cash and $8.63 million in debt, with a net cash position of $825.99 million or $12.65 per share.
| Cash & Cash Equivalents | 800.06M |
| Total Debt | 8.63M |
| Net Cash | 825.99M |
| Net Cash Per Share | $12.65 |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 16.64 |
| Working Capital | 1.05B |
Cash Flow
In the last 12 months, operating cash flow was $109.91 million and capital expenditures -$764,000, giving a free cash flow of $109.15 million.
| Operating Cash Flow | 109.91M |
| Capital Expenditures | -764,000 |
| Depreciation & Amortization | 1.59M |
| Net Borrowing | n/a |
| Free Cash Flow | 109.15M |
| FCF Per Share | $1.67 |
Margins
Gross margin is 99.80%, with operating and profit margins of 58.56% and 62.04%.
| Gross Margin | 99.80% |
| Operating Margin | 58.56% |
| Pretax Margin | 63.49% |
| Profit Margin | 62.04% |
| EBITDA Margin | 58.85% |
| EBIT Margin | 58.56% |
| FCF Margin | 19.78% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.19% |
| Shareholder Yield | -8.19% |
| Earnings Yield | 3.63% |
| FCF Yield | 1.23% |
Analyst Forecast
The average price target for PTGX is $182.36, which is 34.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $182.36 |
| Price Target Difference | 34.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 108.20% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 67.25 and a Piotroski F-Score of 5.
| Altman Z-Score | 67.25 |
| Piotroski F-Score | 5 |